Conducting pathway analyses to accelerate discovery research

Researchers at Harvard University wanted to let biologists self-serve omics data analysis so the bioinformatics team wasn't a bottleneck, in order to make go/no-go drug-development decisions. They used Clarivate's pathway-analysis solutions to independently analyze omics data. This gave researchers an "understanding of omics data in the context of their therapeutic area," enabling more informed decisions about which candidates to advance through the development pipeline. No further quantitative outcomes are stated on the page.

Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.